By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



P.O. Box 12878

Research Triangle Park  North Carolina  27709  U.S.A.
Phone: 919-544-8600 Fax: 919-544-8697




Merck & Co.  Antifungals

Company News
SCYNEXIS, Inc. (SCYX) Reports Second Quarter 2014 Financial Results 8/13/2014 7:32:54 AM
SCYNEXIS, Inc. (SCYX) To Present At Canaccord Genuity Growth Conference 2014 8/6/2014 8:44:33 AM
SCYNEXIS, Inc. (SCYX) To Present At JMP Securities Healthcare Conference 6/18/2014 8:57:42 AM
SCYNEXIS, Inc. (SCYX) Provides Update On Corporate Progress And First Quarter 2014 Financial Results 6/16/2014 7:39:38 AM
After Three Delays, SCYNEXIS, Inc. (SCYX) Finally Goes IPO At $10 A Share 5/2/2014 10:51:11 AM
SCYNEXIS, Inc. Announces Launch Of Initial Public Offering Of Common Stock 3/24/2014 9:44:57 AM
Durham's SCYNEXIS, Inc. Files For $55 Million IPO 3/3/2014 7:47:31 AM
SCYNEXIS, Inc. Appoints Carole Sable, MD, As Chief Medical Officer 2/24/2014 6:44:30 AM
SCYNEXIS, Inc. Receives Qualified Infectious Disease Product (QIDP) Designation From The FDA For Antifungal Agent SCY-078 For Oral Use 2/21/2014 9:05:24 AM
SCYNEXIS, Inc. Appoints Vivian Doelling As Vice President Of Animal Health 11/20/2013 11:31:34 AM